We aimed to 1) examine disability and survival in patients with ANNA1/Hu-IgG paraneoplastic neurological syndromes (PNS), and 2) compare survival to small cell lung cancer (SCLC) without PNS.
No takes yet. Share an insight, caveat, or question.
DiMauro et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: